Geron Stock (NASDAQ:GERN)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$4.25

52W Range

$1.64 - $5.34

50D Avg

$4.31

200D Avg

$3.80

Market Cap

$2.49B

Avg Vol (3M)

$8.10M

Beta

0.52

Div Yield

-

GERN Company Profile


Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

141

IPO Date

Jul 31, 1996

Website

GERN Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceSep 24
Chargeback And Distributor Service Fees$-4.00M
Government Rebates$-364.00K
Product$28.21M
Revenues Before Adjustments$32.66M
Sales Returns And Allowance$-82.00K
Total Gross To Net Adjustments$-4.45M

Fiscal year ends in Dec 23 | Currency in USD

GERN Financial Summary


Dec 23Dec 22Dec 21
Revenue$237.00K$596.00K$1.39M
Operating Income$-193.94M$-138.55M$-114.00M
Net Income$-184.13M$-141.03M$-120.95M
EBITDA$-192.91M$-135.02M$-111.59M
Basic EPS$-0.32$-0.37$-0.37
Diluted EPS$-0.32$-0.37$-0.37

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Nov 07, 24 | 11:20 AM
Q2 24Aug 08, 24 | 12:05 PM
Q1 24May 02, 24 | 12:00 AM

Peer Comparison


TickerCompany
XFORX4 Pharmaceuticals, Inc.
TGTXTG Therapeutics, Inc.
PTCTPTC Therapeutics, Inc.
CWBRCohBar, Inc.
PDSBPDS Biotechnology Corporation
SRPTSarepta Therapeutics, Inc.
AVROAVROBIO, Inc.
VKTXViking Therapeutics, Inc.
EFTReFFECTOR Therapeutics, Inc.
IMMXImmix Biopharma, Inc.
OCEAOcean Biomedical, Inc.
HEPAHepion Pharmaceuticals, Inc.
MDGLMadrigal Pharmaceuticals, Inc.
ZURAZura Bio Limited
ELEVElevation Oncology, Inc.
ENVBEnveric Biosciences, Inc.